Ken Fisher’s Solid Biosciences SLDB Stock Holding History

Ken Fisher’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$745K	Hold	103,481	–	–	﹤0.01%	720
2025 Q4	$584K	Buy	+103,481	New	+$561K	﹤0.01%	751

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ken Fisher's SLDB Position: Q1 2026 in Review

Ken Fisher held its Solid Biosciences (SLDB) position steady in Q1 2026 at 103,481 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Ken Fisher first reported a position in SLDB in Q4 2025 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

Ken Fisher held 103,481 shares of Solid Biosciences worth $745K as of Q1 2026.
Ken Fisher left its Solid Biosciences share count unchanged in Q1 2026.
Solid Biosciences made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #720 holding.
Ken Fisher first reported a position in Solid Biosciences in Q4 2025 and has held it in 2 quarters since.
150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.